The Georgetown Company and Beacon Capital Partners, in collaboration with ZoE Life Sciences, have announced plans for a seven-story life science facility at 707 Eleventh Avenue in Hell’s Kitchen. Designed by Elkus Manfredi, the 185,000-square-foot structure is located between West 50th and 51st Streets. The new development is supported by the New York City Industrial Development Agency and managed by the New York City Economic Development Corporation, and will feature laboratory, research, and office spaces.
This initiative marks the first ground-up, purpose-built life science property in Manhattan in over a decade. The facility will feature rooftop solar panels, private terraces, and floor-to-ceiling windows. In addition, it is planned to feature a day-to-night cafe and wine bar in the lobby and an array of other modern amenities. The project is aiming for LEED Gold and WELL certification.
Renderings show the façade composed of green metal paneling surrounding oversized-floor-to ceiling windows. The northern end of the main eastern elevation features broader stretches of glass, and a landscaped terrace caps the parapet.
“The Far West Side is quickly becoming a hub for life sciences investment and research,” said Jonathan Schmerin, managing principal at Georgetown Company. “We are honored to partner with Beacon and NYCEDC on our shared vision for this project and the advancement of New York’s life sciences industry.”
The project is part of a broader expansion of the life science sector in Manhattan’s Far West Side, providing a strategic anchor for innovation within the life sciences realm in the area.